Cardinal Health vs Cigna
CAH and CI side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CAH and CI compare
Cigna is the larger company, worth 1.4 times as much as Cardinal Health ($78.8B against $58.3B).
Cardinal Health grew revenue faster over the last twelve months (14.2% versus 7.8% for Cigna).
Both pay dividends: Cardinal Health yields 0.82% and Cigna 2.1%.
Cardinal Health scores higher on the StockData Score (16 against 8 for Cigna), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CAH | CI |
|---|---|---|
| Size and price | ||
| Market cap | $58.3B | $78.8B |
| Share price | $250.48 | $298.23 |
| Change, 1 year | 52.3% | −0.30% |
| Change, 5 years | 406% | 39.3% |
| Beta (5Y) | 0.47 | 0.33 |
| Employees | 64K | 68K |
| StockData Score | ||
| Total score | 16 (better) | 8 |
| Valuation score | 1 | 2 (better) |
| Growth score | 4 (better) | 2 |
| Performance score | 4 (better) | 0 |
| Health score | 3 (better) | 2 |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 34.6× | – |
| P/S | 0.2× (better) | 0.3× |
| P/B | – | 1.8× |
| EV/EBITDA | 17.5× | 8.2× (better) |
| P/FCF | 12.9× | – |
| PEG | 0.44 | – |
| FCF yield | 7.8% | – |
| Fair value | $196.59 | – |
| Margin of safety | −27.4% | – |
| Growth | ||
| Revenue growth (TTM) | 14.2% (better) | 7.8% |
| Revenue growth, 5Y average | 9.4% | 11.4% (better) |
| Net income growth (TTM) | 9.8% | – |
| EPS growth (TTM) | 12.1% | – |
| EPS growth, 5Y average | 28.3% (better) | −0.69% |
| Profitability | ||
| Gross margin | 3.8% | 20.6% (better) |
| Operating margin | 1.0% | 3.5% (better) |
| Net margin | 0.67% | – |
| FCF margin | 1.8% | – |
| Return on invested capital | 136% (better) | 12.1% |
| Financial health | ||
| Debt / equity | – | 0.75 |
| Net debt / EBITDA | 1.13 (better) | 1.94 |
| Interest coverage | 7.5× (better) | 7.2× |
| Current ratio | 0.88 (better) | 0.85 |
| Altman Z-score | 5.11 (better) | 2.80 |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.82% | 2.1% (better) |
| Payout ratio | 28.6% | – |
| Years of dividend growth | 17 (better) | 5 |
| Dividend growth, 5Y average | 1.0% | 173% (better) |
| Buyback yield | 2.3% (better) | 1.3% |
| Shareholder yield | 3.2% | 3.4% (better) |
| Ownership | ||
| Held by institutions | 88.7% | 89.9% |
| Held by insiders | 0.28% | 0.41% |
| Insider net buying, 12 months | −$61.6M (better) | −$65.8M |
| Superinvestors holding | 2 | 4 (better) |
| Short interest, % of float | 3.2% | 2.6% |
Go deeper
- CAH stock overview
- CAH income statement
- CAH valuation and score
- CI stock overview
- CI income statement
- CI valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.